Skip to main content
SpringerLink
Log in

Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The previous published data on the association between the 8-oxo-guanine glycosylase-1 (OGG1) and apurinic/apyrimidinic-endonuclease-1 (APEX1/APE1) polymorphisms and lung cancer risk remained controversial. Several polymorphisms in the OGG1 and APEX1 gene have been described, including the commonly occurring Ser326Cys in OGG1 and Asp148Glu in APEX1. This meta-analysis of literatures was performed to derive a more precise estimation of the relationship. A total of 37 studies were identified to the meta-analysis, including 9,203 cases and 10,994 controls for OGG1 Ser326Cys (from 25 studies) and 3,491 cases and 4,708 controls for APEX1 Asp148Glu (from 12 studies). When all the eligible studies were pooled into the meta-analysis of OGG1 Ser326Cys polymorphism, significantly increased lung cancer risk was observed in recessive model (OR = 1.17, 95 % CI = 1.03–1.33) and in additive model (OR = 1.21, 95 % CI = 1.03–1.42). In the stratified analysis, significantly increased risk of lung cancer was also observed on the population-based studies (recessive model: OR = 1.26, 95 % CI = 1.08–1.46, additive model: OR = 1.42, 95 % CI = 1.06–1.73) and non-smokers (dominant model: OR = 1.20, 95 % CI = 1.02–1.42, recessive model: OR = 1.20, 95 % CI = 1.02–1.40, additive model: OR = 1.35, 95 % CI = 1.08–1.68). Additionally, when one study was deleted in the sensitive analysis, the results of OGG1 Ser326Cys were changed in Asians (recessive model: OR = 1.16, 95 % CI = 1.06–1.27, additive model: OR = 1.23, 95 % CI = 1.09–1.38). When all the eligible studies were pooled into the meta-analysis of APEX1 Asp148Glu polymorphism, there was no evidence of significant association between lung cancer risk and APEX1 Asp148Glu polymorphism in any genetic model. In the stratified analysis, significantly decreased lung adenocarcinoma risk was observed in recessive model (OR = 0.68, 95 % CI = 0.48–0.97, P h = 0.475, I2 = 0.0 %). Additionally, when one study was deleted in the sensitive analysis, the results of APEX1 Asp148Glu were changed in Asians (recessive model: OR = 1.21, 95 % CI = 1.03–1.43) and smokers (dominant model: OR = 1.62, 95 % CI = 1.08–2.44, additive model: OR = 1.37, 95 % CI = 1.02–1.84). In summary, this meta-analysis indicates that OGG1 Ser326Cys show an increased lung cancer risk in Asians and non-smokers, APEX1 Asp148Glu polymorphism may be associated with decreased lung adenocarcinoma risk, and APEX1 Asp148Glu polymorphism show an increased lung cancer risk in Asians and smokers. However, a study with the larger sample size is needed to further evaluated gene-environment interaction on OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Gackowski D, Speina E, Zielinska M, Kowalewski J, Rozalski R, Siomek A, Paciorek T, Tudek B, Olinski R (2003) Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res 63:4899–4902

    PubMed  CAS  Google Scholar 

  3. Pramanik S, Devi S, Chowdhary S, Surendran ST, Krishnamurthi K, Chakrabarti T (2011) DNA repair gene polymorphisms at XRCC1, XRCC3, XPD, and OGG1 loci in Maharashtrian population of central India. Chemosphere 82:941–946

    Article  PubMed  CAS  Google Scholar 

  4. Shiraishi K, Kohno T, Tanai C, Goto Y, Kuchiba A, Yamamoto S, Tsuta K, Nokihara H, Yamamoto N, Sekine I, Ohe Y, Tamura T, Yokota J, Kunitoh H (2010) Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol 28:4945–4952

    Article  PubMed  CAS  Google Scholar 

  5. Vispe S, Yung TM, Ritchot J, Serizawa H, Satoh MS (2000) A cellular defense pathway regulating transcription through poly (ADPribosyl) ation in response to DNA damage. Proc Natl Acad Sci USA 97:9886–9891

    Article  PubMed  CAS  Google Scholar 

  6. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366–374

    Article  PubMed  CAS  Google Scholar 

  7. Wei Q, Cheng L, Hong WK, Spitz MR (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res 56:4103–4107

    PubMed  CAS  Google Scholar 

  8. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92:1764–1772

    Article  PubMed  CAS  Google Scholar 

  9. Shen H, Spitz MR, Qiao Y, Guo Z, Wang LE, Bosken CH, Amos CI, Wei Q (2003) Smoking, DNA repair capacity and risk of non-small cell lung cancer. Int J Cancer 107:84–88

    Article  PubMed  CAS  Google Scholar 

  10. Xi T, Jones IM, Mohrenweiser HW (2004) Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 83:970–979

    Article  PubMed  CAS  Google Scholar 

  11. Pampel FC (2003) Declining sex differences in mortality from lung cancer in high-income nations. Demography 40:45–65

    Article  PubMed  Google Scholar 

  12. Hung RJ, Hall J, Brennan P, Boffetta P (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162:925–942

    Article  PubMed  Google Scholar 

  13. Izumi T, Hazra TK, Boldogh I, Tomkinson AE, Park MS, Ikeda S, Mitra S (2000) Requirement for human AP endonuclease 1 for repair of 3-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogenesis 21:1329–1334

    Article  PubMed  CAS  Google Scholar 

  14. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, Koch M (2001) Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 7:824–830

    PubMed  CAS  Google Scholar 

  15. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, Gao C, Li Z, Wang J, Takezaki T, Tajima K, Varga T, Sawaguchi T, Lum JK, Martinson JJ, Tsugane S, Iwamasa T, Shinmura K, Yokota J (1999) hOGG1 Se r32 6Cy s polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 8:669–674

    PubMed  CAS  Google Scholar 

  16. Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhalder B, Dienemann H, Kayser K, Schulz V, Drings P, Bartsch H (2000) hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int J Cancer 88:932–937

    Article  PubMed  CAS  Google Scholar 

  17. Ito H, Hamajima N, Takezaki T, Matsuo K, Tajima K, Hatooka S, Mitsudomi T, Suyama M, Sato S, Ueda R (2002) A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol 12:258–265

    Article  PubMed  Google Scholar 

  18. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR (2002) Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 11:409–412

    PubMed  Google Scholar 

  19. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R, Yokota J (2002) Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 11:730–738

    PubMed  CAS  Google Scholar 

  20. Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR, Albanes D (2003) Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 191:171–178

    Article  PubMed  CAS  Google Scholar 

  21. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25:2433–2441

    Article  PubMed  CAS  Google Scholar 

  22. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, Nohmi T, Kasai H, Yokota J (1998) Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16:3219–3225

    Article  PubMed  CAS  Google Scholar 

  23. Park J, Chen L, Tockman MS, Elahi A, Lazarus P (2004) The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 14(2):103–109

    Article  PubMed  CAS  Google Scholar 

  24. Vogel U, Nexø BA, Wallin H, Overvad K, Tjønneland A, Raaschou-Nielsen O (2004) No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem Genet 42:453–460

    Article  PubMed  CAS  Google Scholar 

  25. Lan Q, Mumford JL, Shen M, Demarini DM, Bonner MR, He X, Yeager M, Welch R, Chanock S, Tian L, Chapman RS, Zheng T, Keohavong P, Caporaso N, Rothman N (2004) Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 25:2177–2181

    Article  PubMed  CAS  Google Scholar 

  26. Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, Welch R, Chanock S, Keohavong P, Donahue M, Zheng T, Caporaso N, Lan Q (2005) Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res 25:537–542

    PubMed  CAS  Google Scholar 

  27. Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Borel S, Hall J, Boffetta P (2005) Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 97:567–576

    Article  PubMed  CAS  Google Scholar 

  28. Liang GY, Pu YP, Yin LH (2005) Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett 223:265–274

    Article  PubMed  CAS  Google Scholar 

  29. Kohno T, Kunitoh H, Toyama K, Yamamoto S, Kuchiba A, Saito D, Yanagitani N, Ishihara S, Saito R, Yokota J (2006) Association of the OGG1-326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci 97:724–728

    Article  PubMed  CAS  Google Scholar 

  30. Loft S, Svoboda P, Kasai H, Tjønneland A, Vogel U, Møller P, Overvad K, Raaschou-Nielsen O (2006) Prospective study of 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis 27:1245–1250

    Article  PubMed  CAS  Google Scholar 

  31. Sørensen M, Raaschou-Nielsen O, Hansen RD, Tjønneland A, Overvad K, Vogel U (2006) Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic Res 40:885–891

    Article  PubMed  Google Scholar 

  32. Lee CH, Lee KY, Choe KH, Hong YC, Noh SI, Eom SY, Ko YJ, Zhang YW, Yim DH, Kang JW, Kim H, Kim YD (2006) Effects of oxidative DNA damage and genetic polymorphism of the glutathione peroxidase 1 (GPX1) and 8-oxoguanine glycosylase 1 (hOGG1) on lung cancer. J Prev Med Pub Health 39:130–134

    Google Scholar 

  33. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27:560–567

    Article  PubMed  CAS  Google Scholar 

  34. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, Autrup H, Malaveille C, Peluso M, Airoldi L, Veglia F, Gormally E, Hoek G, Krzyzanowski M, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Pera G, Martinez C, Dorronsoro M, Barricarte A, Tormo MJ, Quiros JR, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Vineis P (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27:997–1007

    Article  PubMed  CAS  Google Scholar 

  35. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H (2007) Polymorphisms in base excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 631:101–110

    Article  PubMed  Google Scholar 

  36. Hatt L, Loft S, Risom L, Møller P, Sørensen M, Raaschou-Nielsen O, Overvad K, Tjønneland A, Vogel U (2007) OGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study. Mutat Res 639:45–54

    PubMed  Google Scholar 

  37. Karahalil B, Emerce E, Koçer B, Han S, Alkiş N, Karakaya AE (2008) The association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: a hospital-based case-control study in turkey. Arh Hig Rada Toksikol 59:241–250

    Article  PubMed  CAS  Google Scholar 

  38. Chang CH, Hsiao CF, Chang GC, Tsai YH, Chen YM, Huang MS, Su WC, Hsieh WS, Yang PC, Chen CJ, Hsiung CA (2009) Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan. Am J Epidemiol 170:695–702

    Article  PubMed  Google Scholar 

  39. Miyaishi A, Osawa K, Osawa Y, Inoue N, Yoshida K, Kasahara M, Tsutou A, Tabuchi Y, Sakamoto K, Tsubota N, Takahashi J (2009) MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J Exp Clin Cancer Res 28:10

    Article  PubMed  Google Scholar 

  40. Okasaka T, Matsuo K, Suzuki T, Ito H, Hosono S, Kawase T, Watanabe M, Yatabe Y, Hida T, Mitsudomi T, Tanaka H, Yokoi K, Tajima K (2009) hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J Hum Genet 54:739–745

    Article  PubMed  CAS  Google Scholar 

  41. Agaçhan B, Küçükhüseyin O, Aksoy P, Turna A, Yaylim I, Görmüs U, Ergen A, Zeybek U, Dalan B, Isbir T (2009) Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking. Anticancer Res 29:2417–2420

    PubMed  Google Scholar 

  42. Lu J, Zhang S, Chen D, Wang H, Wu W, Wang X, Lei Y, Wang J, Qian J, Fan W, Hu Z, Jin L, Shen H, Huang W, Wei Q, Lu D (2009) Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J 23:3459–3469

    Article  PubMed  CAS  Google Scholar 

  43. Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, Chen CJ, Hsiung CA (2009) A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 18:223–229

    Article  PubMed  CAS  Google Scholar 

  44. Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K (2011) Association of genetic polymorphisms in DNA repair pathway genes with nonsmall cell lung cancer risk. Lung Cancer 73:138–146

    Article  PubMed  Google Scholar 

  45. Liu CJ, Hsia TC, Tsai RY, Sun SS, Wang CH, Lin CC, Tsai CW, Huang CY, Hsu CM, Bau DT (2010) The joint effect of hOGG1 single nucleotide polymorphism and smoking habit on lung cancer in Taiwan. Anticancer Res 30:4141–4146

    PubMed  CAS  Google Scholar 

  46. Osawa K, Miyaishi A, Uchino K, Osawa Y, Inoue N, Nakarai C, Tsutou A, Kido Y, Yoshimura M, Tsubota N, Takahashi J (2010) APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese. Asian Pac J Cancer Prev 11:1181–1186

    PubMed  Google Scholar 

  47. Li Z, Guan W, Li MX, Zhong ZY, Qian CY, Yang XQ, Liao L, Li ZP, Wang D (2011) Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population. Arch Med Res 42:226–234

    Article  PubMed  CAS  Google Scholar 

  48. Deng Q, Sheng L, Su D, Zhang L, Liu P, Lu K, Ma S (2011) Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Med Oncol 28:667–672

    Article  PubMed  CAS  Google Scholar 

  49. Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, Sato S, Ueda R, Tajima K (2004) Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 25:1395–1401

    Article  PubMed  CAS  Google Scholar 

  50. Loft S, Svoboda P, Kawai K, Kasai H, Sørensen M, Tjønneland A, Vogel U, Møller P, Overvad K, Raaschou-Nielsen O (2012) Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study. Free Radic Biol Med 52:167–172

    Article  PubMed  CAS  Google Scholar 

  51. Janik J, Swoboda M, Janowska B, Cieśla JM, Gackowski D, Kowalewski J, Olinski R, Tudek B, Speina E (2011) 8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes. Mutat Res 709–710:21–31

    PubMed  Google Scholar 

  52. Kohno T, Kunitoh H, Mimaki S, Shiraishi K, Kuchiba A, Yamamoto S, Yokota J (2011) Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma. J Thorac Oncol 6:813–817

    Article  PubMed  Google Scholar 

  53. Davey SG, Egger M (1997) Meta-analyses of randomized controlled trials. Lancet 350:1182

    Google Scholar 

  54. Ioannidis JP, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ (2008) Assessment of cumulative evidence on genetic associations:interim guidelines. Int J Epidemiol 37:120–132

    Article  PubMed  Google Scholar 

  55. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Natl Cancer Inst 22:719–778

    CAS  Google Scholar 

  56. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  57. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  PubMed  CAS  Google Scholar 

  58. Egger M, Smith DG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  PubMed  CAS  Google Scholar 

  59. Hirschhorn JN, Lohmueller K, Byrne E (2002) A comprehensive review of genetic association studies. Genet Med 4:45–61

    Article  PubMed  CAS  Google Scholar 

  60. Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane Collaboration, Oxford

    Book  Google Scholar 

  61. Kiyohara C, Takayama K, Nakanishi Y (2006) Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54:267–283

    Article  PubMed  Google Scholar 

  62. Ji YN, Zhan P, Wang J, Qiu LX, Yu LK (2011) APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis. Mol Biol Rep 38:4537–4543

    Article  PubMed  CAS  Google Scholar 

  63. Li H, Hao X, Zhang W, Wei Q, Chen K (2008) The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17:1739–1745

    Article  PubMed  Google Scholar 

  64. Qian Q, Liu R, Lei Z, You J, Zhou Q, Zhang HT (2011) Meta analysis of association between Ser326Cys polymorphism of hOGG1 gene and risk of lung cancer]. Zhongguo Fei Ai Za Zhi 14:205–210

    PubMed  CAS  Google Scholar 

  65. Guan P, Huang D, Yin Z, Zhou B (2011) Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls. Asian Pac J Cancer Prev 12:1067–1072

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Information Section, Peace Hospital of Changzhi Medical College, Changzhi, 046000, China

    Xiao-Feng He & Shao-Xia Li

  2. Department of Hematology, Peace Hospital of Changzhi Medical College, Changzhi, 046000, China

    Wu Wei

  3. Department of Biological Chemistry, Changzhi Medical College, Changzhi, 046000, China

    Jiao Su

  4. Neurosurgery Department, Nanfang Hospital of Southern Medical University, Guangzhou, 510515, China

    Yi Liu

  5. College of Pharmacy, Jinan University, Guangzhou, 510632, China

    Ying Zhang

  6. Biomedical Imaging Research Center, University of Fukui, Eiheiji, Fukui, 910-1193, Japan

    Wei Wang

  7. Department of ENT, Peace Hospital of Changzhi Medical College, Changzhi, 046000, China

    Jiang-Bo Qin

Authors
  1. Wu Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-Feng He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiang-Bo Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jiao Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shao-Xia Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-Feng He.

Additional information

W. Wei, X.-F. He, and J.-B. Qin have contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wei, W., He, XF., Qin, JB. et al. Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep 39, 11249–11262 (2012). https://doi.org/10.1007/s11033-012-2035-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2035-8

Keywords

Search

Navigation